StormBio is aA development stage, privately held, biopharmaceutical company, focused on the development of therapeutics for treating Highly Pathogenic Influenza.
The company is currently creating a therapeutic murine model for Highly Pathogenic Influenza and is evaluating therapeutic candidates that regulate hypercytokinemia (without disabling the immune system).
